Indications
GLIADEL® Wafer (polifeprosan 20 with carmustine implant) is indicated
in patients with newly diagnosed high-grade malignant glioma as an adjunct to surgery
and radiation.
GLIADEL Wafer is also indicated in patients with recurrent glioblastoma multiforme
as an adjunct to surgery.
Important Safety Information
You should not be given GLIADEL Wafer if you are allergic to carmustine or any of the components of GLIADEL Wafer.
If you are undergoing surgery for malignant glioma and implantation of GLIADEL Wafer, you should be monitored closely for known complications, including convulsions, infections, abnormal wound healing, and swelling of the brain.
If you are pregnant or are planning to become pregnant, you should understand that carmustine, the active component of GLIADEL Wafer, can cause harm to the fetus if given to a pregnant woman.
It is not known if either carmustine, or other components of GLIADEL Wafer are excreted in human milk. Please see additional Important Safety Information below.